NanJing Pharmaceutical Co Ltd
SSE:600713
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
NanJing Pharmaceutical Co Ltd
NanJing Pharmaceutical Co Ltd
Retained Earnings
NanJing Pharmaceutical Co Ltd
Retained Earnings Peer Comparison
1099
601607
600998
000963
Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors
| Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
NanJing Pharmaceutical Co Ltd
SSE:600713
|
Retained Earnings
¥2.6B
|
CAGR 3-Years
21%
|
CAGR 5-Years
26%
|
CAGR 10-Years
51%
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Retained Earnings
¥66.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
29%
|
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Retained Earnings
¥36.1B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
14%
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Retained Earnings
¥14.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
18%
|
CAGR 10-Years
22%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Retained Earnings
¥12.6B
|
CAGR 3-Years
14%
|
CAGR 5-Years
15%
|
CAGR 10-Years
22%
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Retained Earnings
¥17B
|
CAGR 3-Years
14%
|
CAGR 5-Years
20%
|
CAGR 10-Years
22%
|
See Also
What is NanJing Pharmaceutical Co Ltd's Retained Earnings?
Retained Earnings
2.6B
CNY
Based on the financial report for Mar 31, 2024, NanJing Pharmaceutical Co Ltd's Retained Earnings amounts to 2.6B CNY.
What is NanJing Pharmaceutical Co Ltd's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
51%
Over the last year, the Retained Earnings growth was 10%. The average annual Retained Earnings growth rates for NanJing Pharmaceutical Co Ltd have been 21% over the past three years , 26% over the past five years , and 51% over the past ten years .
You don't have any saved screeners yet
